Arcus Biosciences, Inc. (RCUS)
NYSE: RCUS · Real-Time Price · USD
16.64
+2.04 (13.97%)
At close: Oct 13, 2025, 4:00 PM EDT
16.69
+0.05 (0.30%)
After-hours: Oct 13, 2025, 5:50 PM EDT
Arcus Biosciences Market Cap
Arcus Biosciences has a market cap or net worth of $1.77 billion as of October 13, 2025. Its market cap has increased by 26.85% in one year.
Market Cap
1.77B
Enterprise Value
966.56M
1-Year Change
26.85%
Ranking
Category
Stock Price
$16.64
Market Cap Chart
Since March 15, 2018, Arcus Biosciences's market cap has increased from $704.52M to $1.77B, an increase of 151.38%. That is a compound annual growth rate of 12.93%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 10, 2025 | 1.55B | 14.04% |
| Dec 31, 2024 | 1.36B | -4.70% |
| Dec 29, 2023 | 1.43B | -4.52% |
| Dec 30, 2022 | 1.50B | -47.33% |
| Dec 31, 2021 | 2.84B | 68.68% |
| Dec 31, 2020 | 1.69B | 263.88% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Mar 15, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 737.94B |
| Johnson & Johnson | 458.69B |
| AbbVie | 409.74B |
| UnitedHealth Group | 323.81B |
| AstraZeneca | 263.00B |
| Novo Nordisk | 260.80B |
| Novartis AG | 251.30B |
| Abbott Laboratories | 228.91B |